Colley Caroline S, England Elizabeth, Linley John E, Wilkinson Trevor C I
Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom.
Neuroscience, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
Curr Protoc Pharmacol. 2018 Sep;82(1):e44. doi: 10.1002/cpph.44. Epub 2018 Aug 31.
Ion channels play crucial roles in physiology by modulation of cellular functions that include electrical excitability, secretion, cell migration, and gene transcription. They are an important target class for drug discovery and have historically been targeted using small molecule approaches. A significant opportunity exists to target these channels with antibodies and alternative forms of biologics. Antibodies display high specificity, selectivity, and affinity for their target antigen, thus having the potential to target ion channels very precisely. Nonetheless, isolating antibodies to ion channels is challenging due to the difficulties in expression and purification of ion channels in a format suitable for antibody drug discovery and due to the complexities of screening for function. In this overview, we focus on an array of screening methods, ranging from direct antibody binding screens to complex electrophysiological assays, and describe how these assays can be used to identify functional monoclonal antibodies. We also provide some insights into specific considerations which are required to enable these screens to be used for antibody drug discovery. © 2018 by John Wiley & Sons, Inc.
离子通道通过调节包括电兴奋性、分泌、细胞迁移和基因转录在内的细胞功能,在生理学中发挥着关键作用。它们是药物发现的重要靶点类别,并且在历史上一直通过小分子方法进行靶向。利用抗体和其他形式的生物制剂靶向这些通道存在重大机遇。抗体对其靶抗原具有高特异性、选择性和亲和力,因此有可能非常精确地靶向离子通道。尽管如此,由于难以以适合抗体药物发现的形式表达和纯化离子通道,以及功能筛选的复杂性,分离针对离子通道的抗体具有挑战性。在本综述中,我们重点介绍了一系列筛选方法,从直接抗体结合筛选到复杂的电生理测定,并描述了如何使用这些测定来鉴定功能性单克隆抗体。我们还提供了一些关于使这些筛选能够用于抗体药物发现所需的特定考虑因素的见解。© 2018 约翰威立父子公司